Houston teen first in Texas to become own donor to reverse sickle cell anemia
Here's a huge advancement in treating sickle cell disease! A teen patient at Texas Children's Cancer and Hematology Center in Houston is the first patient in Texas to become her own donor to reverse her rare blood disorder.
HOUSTON - 17-year-old Helen Ndku has been suffering severe pain from sickle cell disease her whole life. The first major crisis, when she was only one year old.
"She actually died in my hands, and we called the ambulance," remembers Helen's mother Enita Odofin. "She came back to life, we went to the hospital, but she died there again, before they brought her back to life."
RELATED: Teen cowboy dies on horse but is brought back to life
Helen's life was spared, but her pain wasn't.
"When I was little, I remember times where I'd be in the middle of class, and I just started crying because I was in so much pain. I remember not being in school very often. Going home a lot," explains Helen. "I just remember crying, I cried really hard. It's a pain that goes everywhere. It's kind of like needles, maybe bricks, just stacked on top of you squeezing sometimes pulling? I don't know. Yes, it just feels like your body's decaying in the worst ways possible."
Sickle cell anemia can affect anyone; however, it mostly affects African Americans, followed by Hispanics.
"There's a single genetic mutation that causes the red blood cells, the cells in the body to deliver oxygen to become inflexible," says Dr. Tami John. "Under stress, they will stick like create kind of a sickle C shape, and those themselves then get stuck in small blood vessels throughout the body and cause things like the significant pain. They cause organ damage."
Dr. John is a Pediatric Hematologist-Oncologist who specializes in stem cell transplants at Texas Children's Cancer and Hematology Center, as well as an Assistant Professor at Baylor College of Medicine. She's heading the clinical trial for sickle cell.
Until now, there was only one treatment option for children with sickle cell, but it only helped manage the condition and still often required monthly blood transfusions.
But now, a possible cure is on the horizon and many families and researchers are watching and waiting to see how it works for Helen.
"She's the very first patient at the Texas Medical Center to receive gene modification therapy. There have been others and on this particular clinical trial. There are about 50 other people with sickle cell disease who have received this therapy. She is the first in the Texas Medical Center and the first in Texas, as well as one of the youngest patients," says Dr. John.
RELATED: Toddler paralyzed by rare Guillain-Barr Syndrome still recovering
Helen had her doubts at first. "I didn't have hope for it to be honest. I thought it was a lost cause," explains Helen.
However, she agreed to go for it!
Siblings often act as a stem cell donor, but that wasn't an option for Helen.
"What we were able to do was take stem cells from Helen and take those to a lab where a scientist modified those cells with a new gene, we inserted a new gene and then we were able to give those stem cells back to her and watch them grow and they produced new hemoglobin," explains Dr. John.
It takes one year to find out the results, and it has now been a year for Helen.
CLICK HERE FOR MORE STORIES FROM MELISSA WILSON
"From everything we've seen, she has no evidence of sickle cell disease. She clinically has changed. She's been able to stop all of her chronic pain medications and really start to engage in everyday activities that for years and years, she just wasn't able to do. The concept of a cure is still under discussion in the medical community about gene therapies. Clinically, her symptoms have resolved," exclaims Dr. John.
Because she feels well for the first time ever, Helen just learned how to ride a bike. She can finally sit up straight for longer than an hour, plus she can walk and exercise for the first time.
Helen has more hope than ever but is still adjusting to what it feels like to be pain-free.
"I think it's strange. It's not it's not normal to me to like, not be sick all the time, so it's like foreign land, I don't know how to conquer it yet, but I'm working on it," says Helen. "She's amazing, it's night and day for me," says her smiling mom.
While about 50 other patients have also undergone this procedure, it's still in clinical trials, but doctors believe this could brighten the future of many patients with sickle cell.
"This is a huge breakthrough to be able to discuss and share with patients I think it can be life changing, as we've seen, and the hope is we see it become more and more available," says Dr. John.
RELATED: Couple from Alabama seeks life-saving care for twins at Texas Childrens Hospital
Helen never imagined she'd be well enough to go to college. Now she's doing so well, she may even go out-of-state to her favorite school of choice.
Click here for more information on Texas Children's Sickle Cell Program.
More here:
Houston teen first in Texas to become own donor to reverse sickle cell anemia - FOX 26 Houston
- Cardiovascular Glossary A-Z (All) | Texas Heart Institute - January 4th, 2023
- ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) - Business Wire - September 25th, 2022
- GVHD in the Context of Stem Cell or Allogeneic Transplant - Cancer Network - August 22nd, 2022
- De-extinction Company Aims to Resurrect the Tasmanian Tiger - Scientific American - August 22nd, 2022
- Dean Kamen on the power of celebrating your own obsoletion - TechCrunch - July 27th, 2022
- Westin and Sehn Carve Out the Role of CAR T-Cell Therapy and Transplant in Primary Refractory DLBCL - OncLive - July 27th, 2022
- Unanticipated findings cast new light on the genetic regulation of different brain tumors - Baylor College of Medicine - July 27th, 2022
- Chaotic response in Uvalde, Parkland shooter faces death penalty, mall shooting leaves 3 dead and jury selection begins in Bannon trial | Hot off the... - July 19th, 2022
- Stem Cells, Abortion, Baby Parts, & the Ukraine - Physicians for Life - June 22nd, 2022
- INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT - BioSpace - June 22nd, 2022
- Quizartinib Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy in Patients with Newly Diagnosed FLT3-ITD Positive... - June 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 15th, 2022
- La Conner native raising funds to cure blood cancer - La Conner Weekly News - May 2nd, 2022
- CORRECTING and REPLACING -- Affimed NV - GlobeNewswire - May 2nd, 2022
- StudyFinds Blotter: Other Notable Health Research From April 28, 2022 - Study Finds - May 2nd, 2022
- Sung to lead cancer institute; Bankston wins fellowship - ASBMB Today - April 19th, 2022
- Oleic Acid, a Key to Activating the Brains Fountain of Youth - Neuroscience News - March 25th, 2022
- Stem Cell Therapy Boosts Outcomes for Some Heart Failure Patients - HealthDay - November 22nd, 2021
- Quizartinib Added to Chemotherapy Demonstrates Superior Overall Survival Compared to Chemotherapy Alone in Adult Patients with Newly Diagnosed... - November 22nd, 2021
- BioBridge Global continues history of innovation with umbilical cord collection and processing under cGMP standards for further manufacture - Yahoo... - November 22nd, 2021
- Immatics to Present Update on Lead ACTengine Program IMA203 Targeting PRAME at the Society for Immunotherapy of Cancers 36th Annual Meeting - Yahoo... - November 8th, 2021
- Affimed Announces Poster Presentations at the 63rd American Society of Hematology Annual ... - Tyler Morning Telegraph - November 8th, 2021
- ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting - StreetInsider.com - November 8th, 2021
- The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect - Curetoday.com - October 28th, 2021
- Durham firm offering up to $10,000 for researchers to use its intestinal technology - WRAL Tech Wire - October 16th, 2021
- Elevated cryptic transcription emerges as a common theme in aging mammalian cells - Baylor College of Medicine News - August 31st, 2021
- Insulin-producing implants are being developed to control Type 1 diabetes - Health Europa - August 5th, 2021
- Cryptic Transcription in Mammalian Stem Cells Linked to Aging - Technology Networks - August 5th, 2021
- Overview of DLBCL - Targeted Oncology - August 5th, 2021
- The True Crime Junkies and the Curious Case of a Missing Husband - VICE - August 5th, 2021
- FROM THE LABS: Hispanic Heritage Spotlight: Interview with Dr. Nino Rainusso - Baylor College of Medicine News - November 13th, 2020
- UPMC nurse practitioner hailed 'healthcare hero' on live TV - Altoona Mirror - October 31st, 2020
- BrainStrom Cell Therapeutics (NASDAQ:BCLI) Enters Agreement With Catalent (NYSE:CTLT) For Manufacture Of Its NurOwn Cell Therapy - BP Journal - October 31st, 2020
- Dr. Daisy Ayim, Cosmetic Surgeon, ObGyn, Business Owner and Entrepreneur, Is Revolutionizing The Integration Of Women's Health And Cosmetic Care -... - October 31st, 2020
- Five Indian American Researchers Named Among NIH 2020 New Innovator Awardees - India West - October 21st, 2020
- Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma - Science... - October 21st, 2020
- Biotechnology could change the cattle industry. Will it succeed? - Salon - September 8th, 2020
- STEM CELLS | VitaDrip IV Therapy | Texas - June 26th, 2020
- New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Combination Therapy with BeyondSpring's Plinabulin - BioSpace - June 23rd, 2020
- Tau: Why Alzheimer's Worsens Fast in Some, Slowly in Others - Alzforum - June 23rd, 2020
- Scholarly Perspectives on COVID-19, Part 1: This Was Only a Matter of Time - Southern Newsroom - June 23rd, 2020
- Texas Stem Cell Law Opens Door for Controversial Treatments - June 11th, 2020
- Who's to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal - Science Magazine - June 9th, 2020
- FTC ramps up enforcement with new wave of warning letters - NutraIngredients-usa.com - June 9th, 2020
- UT Student Awarded Prestigious Astronaut Scholarship - UT News | The University of Texas at Austin - June 9th, 2020
- South Sound Community Bands Together To Save Local Lives - southsoundtalk.com - May 7th, 2020
- Pfizer, NYU working on innovative coronavirus vaccine that could be ready by end of summer - NBC News - May 7th, 2020
- How industry hopes to take on COVID-19 - Bioprocess Insider - BioProcess Insider - March 8th, 2020
- Meng Hsieh, Andrew Shubin - The New York Times - March 8th, 2020
- Jimbo Fisher's Kidz1stFund, Aggie Corps of Cadets team up for Be the Match bone marrow donor registry drive - Bryan-College Station Eagle - March 2nd, 2020
- Texas A&M Researcher Named To National List Of Inspiring Black Scientists - Texas A&M University - March 2nd, 2020
- What to do in Madison: March 2-8, 2020 - The Bozho - March 2nd, 2020
- Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy - FOX43.com - February 27th, 2020
- Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and... - February 27th, 2020
- Stem Cell Therapy for Joints & Spine in Austin Texas - January 28th, 2020
- El Paso scientists to deliver 3D bioprinted miniature hearts to the ISS - 3D Printing Industry - January 28th, 2020
- El Paso scientists team up for heart research project at the International Space Station - KVIA El Paso - January 28th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 18th, 2019
- Incoming Faculty Bring New Areas of Research to Rensselaer - Rensselaer Polytechnic Institute - September 24th, 2019
- Nivolumab as an addition to frontline therapy of AML in younger patients - AML Global Portal - September 24th, 2019
- Interview: BIOLIFE4D is The First US Company to Bioprint a Mini-Heart (for Cardiotoxicity Testing) - 3DPrint.com - September 24th, 2019
- Stem cells regrow leg's long bones - WNDU-TV - September 22nd, 2019
- A breakthrough in the battle against citrus greening - Gainesville Sun - September 22nd, 2019
- Comparing Mymetics (OTCMKTS:MYMX) & Crispr Therapeutics (OTCMKTS:CRSP) - TechNewsObserver - September 22nd, 2019
- STEM CELL THERAPY & TREATMENTS Texas Regional Health - September 10th, 2019
- Fast Facts: Stem Cells 101 Vital Record - September 10th, 2019
- Keller, TX Stem Cells | Neuropathy & Pain Centers of Texas - May 31st, 2019
- Arlington Stem Cells | Neuropathy & Pain Centers of Texas - May 1st, 2019
- Houston, Texas Stem Cell Transplants, Richmond, Sugar Land ... - April 21st, 2019
- Fort Worth Stem Cells | Neuropathy and Pain Centers of Texas - April 15th, 2019
- Stem Cell Rejuvenation Therapy | Totalhormonegenetherapy.com - April 15th, 2019
- Our Doctors - Knee Stem Cells - March 17th, 2019
- Stem Cell Treatment Center in Dallas, Texas | Stem Cell ... - March 17th, 2019
- Neuropathy & Pain Centers of Texas - Stem Cells & Neuropathy - February 6th, 2019
- Stem Cell Doctor Dallas Dr. Darcy Brunk | Dallas, Plano ... - January 25th, 2019
- Four Types of Stem Cells - Texas Right to Life - December 15th, 2018
- Texas | The Stem Cellar - December 5th, 2018
- Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth ... - November 16th, 2018
- HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex - October 13th, 2018
- Shooting Up Stem Cells With Ben Greenfield The Down The ... - September 16th, 2018